InMed Pharmaceuticals(INM) - 2022 Q2 - Earnings Call Transcript

InMed Pharmaceuticals Inc. (NASDAQ:INM) Q2 2022 Earnings Conference Call February 15, 2022 2:00 PM ET Corporate Participants Colin Clancy - Senior Director of Investor Relations Eric Adams - President and Chief Executive Officer Bruce Colwill - Chief Financial Officer Eric Hsu - Senior Vice President, Preclinical Research and Development Alexandra Mancini - Senior Vice President, Clinical and Regulatory Affairs Shane Johnson - Senior Vice President and General Manager of BayMedica Conference Call Participan ...